StonvexLoading…
StonvexStonvexStonvexCore line items from STHO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $20.94M | $110.14M | $84.79M | $56.68M |
Operating Income | Not available | $-70.75M | $-47.49M | $-47.77M |
Net Income | $-10.26M | $-64.25M | $-45.11M | $-46.91M |
EPS (Diluted) | $-0.85 | $-4.90 | $-3.40 | $-3.52 |
Total Assets | $480.36M | $570.20M | $595.86M | $589.92M |
Total Liabilities | $240.20M | $304.33M | $302.20M | $293.97M |
Cash & Equivalents | $62.06M | $50.08M | $40.59M | $44.20M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 12.08M | 12.32M | 12.90M | 13.29M |